GlassScriptPhysician profile
Arun Thukkani
NPI 1467573659
$8,131.72
in general payments reported to CMS, 2019-2025
23 companies · $761 in 2025
The $761 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,515 · 2020: $70.80 · 2021: $160 · 2022: $385 · 2023: $2,590 · 2024: $1,648 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,931 · Travel and Lodging: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,931.06 |
| Travel and Lodging | $1,069.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,146.39 | 2021-2025 | Mitraclip, Triclip, Pressurewire |
| Edwards Lifesciences Corporation | $2,013.11 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $855.86 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Medtronic Vascular, INC. | $695.39 | 2019-2020 | |
| Abiomed | $565.51 | 2021-2025 | Impella |
| Livanova USA, INC. | $528.01 | 2019 | |
| W. L. Gore & Associates, INC. | $249.87 | 2024 | Gore Cardioform Septal Occluder |
| Penumbra, INC. | $180.92 | 2021-2022 | |
| Shockwave Medical, INC | $156.27 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $124.26 | 2023-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $110.70 | 2023 | Metacross Otw, Glidewire, Heartrail |
| Teleflex LLC | $104.28 | 2024-2025 | Twin-Pass, Guideliner |
| Acist Medical Systems, INC. | $63.22 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.18 | 2023-2025 | Jardiance |
| Biosense Webster, INC. | $43.80 | 2024 | Na |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $41.28 | 2023 | |
| Novartis Pharmaceuticals Corporation | $39.67 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $37.77 | 2023-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $25.03 | 2024 | |
| Stryker Corporation | $24.86 | 2025 | Clottriever Bold Catheter |
| Irhythm Technologies, INC. | $23.13 | 2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $20.93 | 2023 | |
| Heartflow, INC. | $18.28 | 2023 | Ffrct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Thukkani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.